Gilead Sciences's most recent trend suggests a bullish bias. One trading opportunity on Gilead Sciences is a Bull Put Spread using a strike $87.50 short put and a strike $82.50 long put offers a potential 24.07% return on risk over the next 22 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $87.50 by expiration. The full premium credit of $0.97 would be kept by the premium seller. The risk of $4.03 would be incurred if the stock dropped below the $82.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Gilead Sciences is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Gilead Sciences is bullish.
The RSI indicator is at 58.84 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Gilead Sciences
High cost of hepatitis C treatment pills is hard to swallow
Sun, 27 Jul 2014 20:00:33 GMT
Financial Times – Can a pill be worth $1,000? That question has been debated with increasing intensity since Gilead's Sovaldi treatment for hepatitis C was approved by the US Food and Drug Administration in December. Sovaldi, …
Drug cocktails point the way towards relief for all hepatitis C sufferers
Sun, 27 Jul 2014 20:00:33 GMT
Financial Times – The recent scientific onslaught against hepatitis C is producing remarkable results, as new drugs such as Gilead's Solvadi and Janssen's Olysio come to the market. “This is the first time in history …
Politicizing Gilead's Research And Development Costs For Sovaldi Is A Reckless And Dangerous Misadventure
Fri, 25 Jul 2014 21:52:00 GMT
The push back on Sovaldi
Fri, 25 Jul 2014 18:52:00 GMT
The $84,000 drug debate
Fri, 25 Jul 2014 18:50:00 GMT
Related Posts
Also on Market Tamer…
Follow Us on Facebook